Recommendations on diagnosis and treatment in hepatobiliary surgery under 2019-nCoV epidemic - 03/09/20
Bienvenue sur EM-consulte, la référence des professionnels de santé.
Article gratuit.
Connectez-vous pour en bénéficier!
Summary |
2019 novel coronavirus pneumonia is a serious life-threatening disease and it has affected many people globally, especially the people who live in China. A high prevalence of hepatobiliary diseases has been observed in 2019-nCoV patients and some may require emergency surgery. In the context of the novel coronavirus pneumonia, new challenges have arisen for surgeons in terms of ways to effectively treat outpatients, safety of medical staffs in performing surgery treatment, and the lack of efficient postoperative management and follow-up procedure. It is hoped that through this article, surgeons will have a better system in hepatobiliary diseases classification, treatment selection, and protective measures to improve the clinical practice in accordance with the guidelines for the diagnosis and treatment of the novel coronavirus pneumonia.
Le texte complet de cet article est disponible en PDF.Keywords : Novel coronavirus, Pneumonia, Viral, Hepatobiliary, Surgery
Plan
Vol 44 - N° 4
P. 403-406 - septembre 2020 Retour au numéro
Article précédent
- Does adipose tissue inflammation drive the development of non-alcoholic fatty liver disease in obesity?
- Adryana Cordeiro, Raquel Costa, Nelson Andrade, Cláudia Silva, Natalia Canabrava, Maria João Pena, Ilda Rodrigues, Sara Andrade, Andrea Ramalho
- “Vascular liver diseases: Position paper(s) from the francophone network for vascular liver diseases, the French Association for the Study of the Liver (AFEF), and the European Reference Network on Hepatological Diseases (ERN RARE-LIVER)”
- Aurélie Plessier, Christophe Bureau
Bienvenue sur EM-consulte, la référence des professionnels de santé.